专利检索 ap:("UNIV HOKKAIDO NAT UNIV CORP" OR "UNIV SAPPORO MEDICAL" OR "DNAVEC CORP") AND inv:"KATO KAZUNORI" 第 1 页

1.

发明公开
VIRUS VECTOR FOR PRIME/BOOST VACCINES, WHICH COMPRISES VACCINIA VIRUS VECTOR AND SENDAI VIRUS VECTOR 审中-公开
标题翻译： FOR PRIME-BOOST病毒载体疫苗，痘苗载体和仙台病毒载体

公开(公告)号：EP2631290A4

公开(公告)日：2015-06-10

申请号：EP11834485

申请日：2011-10-21

申请人： UNIV HOKKAIDO NAT UNIV CORP , UNIV SAPPORO MEDICAL , DNAVEC CORP

发明人： SHIDA HISATOSHI , SOBUE TOMOYOSHI , KATO KAZUNORI , INOUE MAKOTO , HASEGAWA MAMORU

IPC分类号： C12N15/09

CPC分类号： A61K39/39 , A61K39/12 , A61K39/21 , A61K2039/53 , A61K2039/545 , C12N15/86 , C12N2710/24143 , C12N2740/16034 , C12N2740/16134 , C12N2760/18843

摘要： To provide a set of virus vectors which can be used for producing a prime/boost vaccine that can activate both cellular immunity and humoral immunity and is effective on infections by pathogenic microorganisms and malignant tumors which are generally believed to be difficult to be treated by vaccine therapy. [Solution] Provided is a set of virus vectors for prime/boost vaccines, comprising the following virus vector (a) and virus vector (b): (a) a vaccinia virus vector which carries a gene encoding an immunogenic polypeptide in such a manner that the gene can be expressed; and (b) a Sendal virus vector which carries the gene encoding the immunogenic polypeptide in such a manner that the gene can be expressed.

2.

发明公开
ANTIBODY DIRECTED AGAINST PAP2a AND USE THEREOF FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES 审中-公开
标题翻译：反对PAP2A LOOKING抗体及其用于治疗目的和诊断

公开(公告)号：EP1908825A4

公开(公告)日：2009-07-08

申请号：EP06756566

申请日：2006-05-17

申请人： UNIV SAPPORO MEDICAL

发明人： HAMADA HIROFUMI , NAKAMURA KIMINORI , KATO KAZUNORI

IPC分类号： C12N15/00 , A61K39/395 , A61P35/00 , C07K16/28 , C07K16/40 , C12N5/10 , C12N15/09 , C12P21/08 , C12Q1/02 , C12Q1/68 , C12Q1/70 , G01N33/574

CPC分类号： C07K16/40 , A61K2039/505 , C07K16/2803 , C07K16/2884 , C12Q1/42 , G01N33/57415 , G01N33/57423 , G01N33/57434 , G01N33/57438 , G01N33/57449

摘要： The purpose is to develop a gene delivery system which has a high selectivity to a target cell and can introduce and express a gene with high efficiency, particularly to develop such a system for use in a gene delivery therapy using a viral vector. A method for targeting a drug, the method comprising the step of delivering a drug containing a therapeutic gene to a target site using an anti-PAP2a antibody.